Skip to main content
ATTO
NASDAQ Life Sciences

Attovia's ATTO-1310 Shows Clinical Proof of Concept; Cash Runway Extended to 2030

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Healthcare
Sentiment info
Positive
Importance info
8
Price
$23.13
Mkt Cap
$1.054B
52W Low
$16.15
52W High
$24.32
52W Position info
43% above low
Off High info
4.9% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

ATTO sits 43% above its 52-week low of $16.15 on light trading volume (0.2× avg).

Summary

Attovia reported Q2 2026 results with preliminary clinical proof of concept for ATTO-1310 in chronic pruritus and high-itch atopic dermatitis. A single dose produced rapid, deep itch relief and consistent lesion control, validating the ATTOBODY platform. Complete Phase 1b data are expected in Q4 2026, with two Phase 2 studies planned for 1H 2027. The upsized IPO raised $332.4 million gross, extending cash runway into 2030. This follows recent insider buying by Frazier Life Sciences and Director Colin Walsh, signaling confidence. The stock trades near its 52-week high, reflecting positive sentiment.

At the time of this announcement, ATTO was trading at $23.13 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $16.15 to $24.32. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

ATTO - Latest Insights

ATTO
Nov 09, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $15.96
Real-time Price: $15.10 info
Change: -$0.860 (-5%) info
Market Cap: $690.259M info
ATTO
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $14.95
Real-time Price: $15.10 info
Change: +$0.150 (+1%) info
Market Cap: $690.259M info
ATTO
Sep 02, 2026, 4:21 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $23.13
Real-time Price: $15.10 info
Change: -$8.03 (-35%) info
Market Cap: $690.259M info
ATTO
Aug 28, 2026, 5:38 PM EDT
Filing Type: 4/A
Importance Score:
7
Price at Filing: $20.70
Real-time Price: $15.10 info
Change: -$5.60 (-27%) info
Market Cap: $690.259M info
ATTO
Aug 13, 2026, 9:52 PM EDT
Filing Type: 4
Importance Score:
8
Price at Filing: $19.18
Real-time Price: $15.10 info
Change: -$4.08 (-21%) info
Market Cap: $690.259M info